Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Expandable DNA-origami rings as a nanomechanical platform for studying disordered nucleoporins.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Surface EEG to Identify Cognitive Motor Dissociation After Acute Brain Injury.
Journal: Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
Published: July 03, 2026
Determinants of Delayed Recovery of Consciousness After Analgosedation Discontinuation in the ICU: Insights From Patients With COVID-19 Hypoxemic Respiratory Failure.
Journal: Critical care medicine
Published: June 15, 2026
Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.
Journal: Targeted oncology
Published: June 11, 2026
Clinically unresponsive patients with acute brain injury activate a brain-computer interface.
Journal: Brain : a journal of neurology
Published: February 27, 2026
Anaemia, hypoalbuminemia, and risk of cycloserine-associated neuropsychiatric toxicity in a shortened oral regimen for multidrug/rifampicin-resistant TB.
Journal: IJTLD open
Published: February 19, 2026
Surface EEG to identify cognitive motor dissociation after acute brain injury PREPRINT.
Journal: medRxiv : the preprint server for health sciences
Published: December 25, 2025
Accuracy of electronic medical records to quantify rates of sedative and analgesic infusions for acute disorders of consciousness big data research.
Journal: medRxiv : the preprint server for health sciences
Published: December 17, 2025
Accuracy of Electronic Medical Records for Quantifying Rates of Sedative and Analgesic Infusions for Acute Disorders of Consciousness in Big Data Research.
Journal: Neurocritical care
Published: December 11, 2025
HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 10, 2025
Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised, placebo-controlled study.
Journal: The Lancet. Neurology
Published: July 22, 2025
Last Updated: 11/08/2026